Arcadia Biosciences (RKDA) Asset Utilization Ratio (2015 - 2025)

Arcadia Biosciences' Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.64 for Q4 2025.

• Quarterly Asset Utilization Ratio rose 82.99% year-over-year to 0.64 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.64 (up 82.99% YoY) and the FY2025 annual result came in at 0.48, up 59.45% from the prior year.
• Asset Utilization Ratio was 0.64 for Q4 2025 at Arcadia Biosciences, up from 0.63 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 20.48 in Q1 2022 and bottomed at 0.08 in Q3 2023.
• A 5-year average of 3.31 and a median of 0.36 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2021 — Asset Utilization Ratio surged 35227.87% — and 2023, when it plunged 121.19%.
• Arcadia Biosciences' Asset Utilization Ratio stood at 16.38 in 2021, then slumped by 99.45% to 0.09 in 2022, then soared by 138.4% to 0.21 in 2023, then surged by 64.53% to 0.35 in 2024, then surged by 82.99% to 0.64 in 2025.
• Business Quant data shows RKDA's Asset Utilization Ratio at 0.64 in Q4 2025, 0.63 in Q3 2025, and 0.52 in Q2 2025.